 | • レポートコード：GIR-22F17920 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Immunodeficient Mouse Models Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の免疫不全マウスモデルの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 免疫不全マウスモデル市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・従来型免疫不全モデル、重症免疫不全モデル、次世代重症免疫不全モデル アプリケーション別セグメントは次のように区分されます。 ・免疫学、感染症、がん、幹細胞生物学、その他 世界の免疫不全マウスモデル市場の主要な市場プレーヤーは以下のとおりです。 ・The Jackson Laboratory、Charles River Laboratories、Taconic Biosciences、Envigo、Janvier Labs、GemPharmatech、GenOway、Applied StemCell、Fred Hutch、Mary Lyon Centre、Hera BioLabs、Champions Oncology、AXENIS、Pharmatest、Lonza、Biocytogen、Altogen Labs、Cyagen 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、免疫不全マウスモデル製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な免疫不全マウスモデルメーカーの企業概要、2019年～2022年までの免疫不全マウスモデルの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な免疫不全マウスモデルメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別免疫不全マウスモデルの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの免疫不全マウスモデルのタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での免疫不全マウスモデル市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および免疫不全マウスモデルの産業チェーンを掲載しています。 ・第13、14、15章では、免疫不全マウスモデルの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 免疫不全マウスモデルの概要 - タイプ別分析（2017年vs2021年vs2028年）：従来型免疫不全モデル、重症免疫不全モデル、次世代重症免疫不全モデル - アプリケーション別分析（2017年vs2021年vs2028年）：免疫学、感染症、がん、幹細胞生物学、その他 - 世界の免疫不全マウスモデル市場規模・予測 - 世界の免疫不全マウスモデル生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - The Jackson Laboratory、Charles River Laboratories、Taconic Biosciences、Envigo、Janvier Labs、GemPharmatech、GenOway、Applied StemCell、Fred Hutch、Mary Lyon Centre、Hera BioLabs、Champions Oncology、AXENIS、Pharmatest、Lonza、Biocytogen、Altogen Labs、Cyagen ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：従来型免疫不全モデル、重症免疫不全モデル、次世代重症免疫不全モデル ・アプリケーション別分析2017年-2028年：免疫学、感染症、がん、幹細胞生物学、その他 ・免疫不全マウスモデルの北米市場分析 - 免疫不全マウスモデルの北米市場：タイプ別市場規模2017年-2028年 - 免疫不全マウスモデルの北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・免疫不全マウスモデルのヨーロッパ市場分析 - ：免疫不全マウスモデルのヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：免疫不全マウスモデルのヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・免疫不全マウスモデルのアジア太平洋市場分析 - 免疫不全マウスモデルのアジア太平洋市場：タイプ別市場規模2017年-2028年 - 免疫不全マウスモデルのアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・免疫不全マウスモデルの南米市場分析 - 免疫不全マウスモデルの南米市場：タイプ別市場規模2017年-2028年 - 免疫不全マウスモデルの南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・免疫不全マウスモデルの中東・アフリカ市場分析 - 免疫不全マウスモデルの中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 免疫不全マウスモデルの中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Immunodeficient Mouse Models market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Immunodeficient Mouse Models market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Immunology accounting for % of the Immunodeficient Mouse Models global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Traditional Immunodeficient Models segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Immunodeficient Mouse Models include The Jackson Laboratory, Charles River Laboratories, Taconic Biosciences, Envigo, and Janvier Labs, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Immunodeficient Mouse Models market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Traditional Immunodeficient Models
Severe Immunodeficient Models
Next-generation Severe Immunodeficient Models
Market segment by Application can be divided into
Immunology
Infectious Disease
Cancer
Stem Cell Biology
Other
The key market players for global Immunodeficient Mouse Models market are listed below:
The Jackson Laboratory
Charles River Laboratories
Taconic Biosciences
Envigo
Janvier Labs
GemPharmatech
GenOway
Applied StemCell
Fred Hutch
Mary Lyon Centre
Hera BioLabs
Champions Oncology
AXENIS
Pharmatest
Lonza
Biocytogen
Altogen Labs
Cyagen
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Immunodeficient Mouse Models product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Immunodeficient Mouse Models, with price, sales, revenue and global market share of Immunodeficient Mouse Models from 2019 to 2022.
Chapter 3, the Immunodeficient Mouse Models competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immunodeficient Mouse Models breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Immunodeficient Mouse Models market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immunodeficient Mouse Models.
Chapter 13, 14, and 15, to describe Immunodeficient Mouse Models sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Immunodeficient Mouse Models Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Immunodeficient Mouse Models Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Traditional Immunodeficient Models
1.2.3 Severe Immunodeficient Models
1.2.4 Next-generation Severe Immunodeficient Models
1.3 Market Analysis by Application
1.3.1 Overview: Global Immunodeficient Mouse Models Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Immunology
1.3.3 Infectious Disease
1.3.4 Cancer
1.3.5 Stem Cell Biology
1.3.6 Other
1.4 Global Immunodeficient Mouse Models Market Size & Forecast
1.4.1 Global Immunodeficient Mouse Models Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Immunodeficient Mouse Models Sales in Volume (2017-2028)
1.4.3 Global Immunodeficient Mouse Models Price (2017-2028)
1.5 Global Immunodeficient Mouse Models Production Capacity Analysis
1.5.1 Global Immunodeficient Mouse Models Total Production Capacity (2017-2028)
1.5.2 Global Immunodeficient Mouse Models Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Immunodeficient Mouse Models Market Drivers
1.6.2 Immunodeficient Mouse Models Market Restraints
1.6.3 Immunodeficient Mouse Models Trends Analysis
2 Manufacturers Profiles
2.1 The Jackson Laboratory
2.1.1 The Jackson Laboratory Details
2.1.2 The Jackson Laboratory Major Business
2.1.3 The Jackson Laboratory Immunodeficient Mouse Models Product and Services
2.1.4 The Jackson Laboratory Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Charles River Laboratories
2.2.1 Charles River Laboratories Details
2.2.2 Charles River Laboratories Major Business
2.2.3 Charles River Laboratories Immunodeficient Mouse Models Product and Services
2.2.4 Charles River Laboratories Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Taconic Biosciences
2.3.1 Taconic Biosciences Details
2.3.2 Taconic Biosciences Major Business
2.3.3 Taconic Biosciences Immunodeficient Mouse Models Product and Services
2.3.4 Taconic Biosciences Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Envigo
2.4.1 Envigo Details
2.4.2 Envigo Major Business
2.4.3 Envigo Immunodeficient Mouse Models Product and Services
2.4.4 Envigo Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Janvier Labs
2.5.1 Janvier Labs Details
2.5.2 Janvier Labs Major Business
2.5.3 Janvier Labs Immunodeficient Mouse Models Product and Services
2.5.4 Janvier Labs Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GemPharmatech
2.6.1 GemPharmatech Details
2.6.2 GemPharmatech Major Business
2.6.3 GemPharmatech Immunodeficient Mouse Models Product and Services
2.6.4 GemPharmatech Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 GenOway
2.7.1 GenOway Details
2.7.2 GenOway Major Business
2.7.3 GenOway Immunodeficient Mouse Models Product and Services
2.7.4 GenOway Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Applied StemCell
2.8.1 Applied StemCell Details
2.8.2 Applied StemCell Major Business
2.8.3 Applied StemCell Immunodeficient Mouse Models Product and Services
2.8.4 Applied StemCell Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Fred Hutch
2.9.1 Fred Hutch Details
2.9.2 Fred Hutch Major Business
2.9.3 Fred Hutch Immunodeficient Mouse Models Product and Services
2.9.4 Fred Hutch Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Mary Lyon Centre
2.10.1 Mary Lyon Centre Details
2.10.2 Mary Lyon Centre Major Business
2.10.3 Mary Lyon Centre Immunodeficient Mouse Models Product and Services
2.10.4 Mary Lyon Centre Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Hera BioLabs
2.11.1 Hera BioLabs Details
2.11.2 Hera BioLabs Major Business
2.11.3 Hera BioLabs Immunodeficient Mouse Models Product and Services
2.11.4 Hera BioLabs Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Champions Oncology
2.12.1 Champions Oncology Details
2.12.2 Champions Oncology Major Business
2.12.3 Champions Oncology Immunodeficient Mouse Models Product and Services
2.12.4 Champions Oncology Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 AXENIS
2.13.1 AXENIS Details
2.13.2 AXENIS Major Business
2.13.3 AXENIS Immunodeficient Mouse Models Product and Services
2.13.4 AXENIS Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Pharmatest
2.14.1 Pharmatest Details
2.14.2 Pharmatest Major Business
2.14.3 Pharmatest Immunodeficient Mouse Models Product and Services
2.14.4 Pharmatest Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Lonza
2.15.1 Lonza Details
2.15.2 Lonza Major Business
2.15.3 Lonza Immunodeficient Mouse Models Product and Services
2.15.4 Lonza Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Biocytogen
2.16.1 Biocytogen Details
2.16.2 Biocytogen Major Business
2.16.3 Biocytogen Immunodeficient Mouse Models Product and Services
2.16.4 Biocytogen Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Altogen Labs
2.17.1 Altogen Labs Details
2.17.2 Altogen Labs Major Business
2.17.3 Altogen Labs Immunodeficient Mouse Models Product and Services
2.17.4 Altogen Labs Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Cyagen
2.18.1 Cyagen Details
2.18.2 Cyagen Major Business
2.18.3 Cyagen Immunodeficient Mouse Models Product and Services
2.18.4 Cyagen Immunodeficient Mouse Models Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Immunodeficient Mouse Models Breakdown Data by Manufacturer
3.1 Global Immunodeficient Mouse Models Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Immunodeficient Mouse Models Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Immunodeficient Mouse Models
3.4 Market Concentration Rate
3.4.1 Top 3 Immunodeficient Mouse Models Manufacturer Market Share in 2021
3.4.2 Top 6 Immunodeficient Mouse Models Manufacturer Market Share in 2021
3.5 Global Immunodeficient Mouse Models Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Immunodeficient Mouse Models Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Immunodeficient Mouse Models Market Size by Region
4.1.1 Global Immunodeficient Mouse Models Sales in Volume by Region (2017-2028)
4.1.2 Global Immunodeficient Mouse Models Revenue by Region (2017-2028)
4.2 North America Immunodeficient Mouse Models Revenue (2017-2028)
4.3 Europe Immunodeficient Mouse Models Revenue (2017-2028)
4.4 Asia-Pacific Immunodeficient Mouse Models Revenue (2017-2028)
4.5 South America Immunodeficient Mouse Models Revenue (2017-2028)
4.6 Middle East and Africa Immunodeficient Mouse Models Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Immunodeficient Mouse Models Sales in Volume by Type (2017-2028)
5.2 Global Immunodeficient Mouse Models Revenue by Type (2017-2028)
5.3 Global Immunodeficient Mouse Models Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Immunodeficient Mouse Models Sales in Volume by Application (2017-2028)
6.2 Global Immunodeficient Mouse Models Revenue by Application (2017-2028)
6.3 Global Immunodeficient Mouse Models Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Immunodeficient Mouse Models Sales by Type (2017-2028)
7.2 North America Immunodeficient Mouse Models Sales by Application (2017-2028)
7.3 North America Immunodeficient Mouse Models Market Size by Country
7.3.1 North America Immunodeficient Mouse Models Sales in Volume by Country (2017-2028)
7.3.2 North America Immunodeficient Mouse Models Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Immunodeficient Mouse Models Sales by Type (2017-2028)
8.2 Europe Immunodeficient Mouse Models Sales by Application (2017-2028)
8.3 Europe Immunodeficient Mouse Models Market Size by Country
8.3.1 Europe Immunodeficient Mouse Models Sales in Volume by Country (2017-2028)
8.3.2 Europe Immunodeficient Mouse Models Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Immunodeficient Mouse Models Sales by Type (2017-2028)
9.2 Asia-Pacific Immunodeficient Mouse Models Sales by Application (2017-2028)
9.3 Asia-Pacific Immunodeficient Mouse Models Market Size by Region
9.3.1 Asia-Pacific Immunodeficient Mouse Models Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Immunodeficient Mouse Models Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Immunodeficient Mouse Models Sales by Type (2017-2028)
10.2 South America Immunodeficient Mouse Models Sales by Application (2017-2028)
10.3 South America Immunodeficient Mouse Models Market Size by Country
10.3.1 South America Immunodeficient Mouse Models Sales in Volume by Country (2017-2028)
10.3.2 South America Immunodeficient Mouse Models Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Immunodeficient Mouse Models Sales by Type (2017-2028)
11.2 Middle East & Africa Immunodeficient Mouse Models Sales by Application (2017-2028)
11.3 Middle East & Africa Immunodeficient Mouse Models Market Size by Country
11.3.1 Middle East & Africa Immunodeficient Mouse Models Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Immunodeficient Mouse Models Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Immunodeficient Mouse Models and Key Manufacturers
12.2 Manufacturing Costs Percentage of Immunodeficient Mouse Models
12.3 Immunodeficient Mouse Models Production Process
12.4 Immunodeficient Mouse Models Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Immunodeficient Mouse Models Typical Distributors
13.3 Immunodeficient Mouse Models Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer